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Abstract
Dental implants are the gold standard of restorative dentistry today.  Implants
have been used for several years in Orthopedics.  Dental implants are an important
treatment option for several patients today.  When a patient is fully or partially dentate,
they are given the opportunity to restore their dentition in ways similar to their natural
oral cavity. The past literature states that titanium is one of the first metals used in
implant placement.  There have been many improvements made on this material.  Most
modifications have been used in order to promote more bone growth around these
implants.  Several different coating materials have been used to increase bone formation.
Titanium (Ti) surfaces have been coated with hydroxyapatite (HA), plasma spray, and
several blasting techniques have been implemented. Tricalcium phosphate (TCP) is a
coating that has been used for several years.  Due to its porosity and likeness to natural
bone, many feel that it is an ideal coating for both dental and orthopedic titanium
implants.  We believe that TCP coated titanium increases the amount of osteoblastic cell
attachment and early bone producing biomarker proteins in osteoblastic cells when
compared to HA coated titanium and titanium only materials.
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1Chapter 1.  Introduction
1.1 Bone Composition and Classifications
Bone is a connective tissue that consists of a complex composite of cells and
extracellular matrix.  Bone cells include osteocytes, osteoprogenitor cells, osteoblasts,
and osteoclasts.  Each of these cells is related to different functions of cell activation,
matrix maturation, mineralization, and remodeling.  The extracellular matrix contains
Type I collagen and ground substance.  Ground substance is an aggregate of proteoglycan
and noncollagenous glycoproteins that become mineralized.  The minerals include
calcium and phosphorous and are stored as hydroxyapatite crystals.  Through
mineralization, bone obtains its rigid structure and function: support and protection of the
musculoskeletal system and a physiologic reservoir of calcium and phosphorous.1
There are many bone classifications.  Dense compact bone forms an outer shell
for an inner meshwork of anastomosing spicules of cancellous bone.  Woven bone is
formed during growth and development and in response to injury.  It is a highly cellular
osseous tissue with low mineral content, random fiber orientation and minimal strength.
It is usually formed at a rate of 3-50um/day or more and is replaced with lamellar bone.
Woven bone is essential to initial healing of endosseous implants.  Lamellar bone is the
mature load bearing bone that comprises most of the adult skeleton.  The bone is densely
mineralized and highly organized into the following structural units:
• Circumferential lamellae-forms a perimeter of compact bone that encases
concentric and interstitial lamellae.
• Concentric lamellae-encases the Haversian canals to form osteons.
2• Interstitial lamellae-irregular shaped remnants of concentric lamellae
All of these units create the Haversian system which encases the neural and vascular
tissue of bone.1, 2
1.2 Osteoinduction and Osteoconduction
Bone formation is a complex series of changes that occur leading to newly formed
structures.  In essence, when an endosseous wound is formed, two stages occur that
comprise this wound healing.  There is an osteoinduction and osteoconduction portion.
These two terms are interrelated but not identical.  In the osteoinduction stage, there is a
phenotypic conversion of mesenchymal cells into bone-forming cells.3  Mesynchymal
cells are undifferentiated and they are stimulated to turn into osteoblasts and osteocytes.
Osteoconduction is defined differently than osteoinduction.  It is appositional
growth permitting bone formation on a surface or down into the pores, channels, or pipes.
It relies on the migration of differentiating osteogenic cells to different surfaces (i.e. the
implant surface).3  Undifferentiated mesenchymal cells migrate to the implant surfaces,
attach and proliferate.  Different environmental factors determine whether or not
mesenchymal cells will differentiate into fibroblasts, chondrocytes, or osteoblasts.
Adherence can occur when the cell itself directly binds to the surface or when it binds to
arginine-glycine-aspartic acid containing proteins on the surface.  At this time, the
mesenchymal cells undergo osteoblastic differentiation.  Mesenchymal cells are sensitive
to surface properties such as surface energy, roughness, and topography.4,5  The new
osteoblasts produce osteoid which includes matrix vesicles and growth factors.
31.3 Bone Healing and Remodeling
Remodeling is the process of old or damaged bone being replaced by new bone.
The rate of bone turnover is approximately 5% for cortical bone and up to 15% for
trabecular bone.  Damaged/old bone is resorbed by osteoclasts which form a cutting cone.
Osteoblasts differentiate behind the cutting cone to form a filling cone.  Osteoblasts in the
filling cone synthesize osteoid which becomes the mineralized osteons.  Osteoblasts
differentiate into osteocytes during mineralization and maturation of bone.1
After implant surgery, bone healing and remodeling is broken into three phases.
The first phase is the inflammatory phase.  This takes place during the 1st 10 days after
surgery.  At this time, adsorption of plasma proteins, platelet aggregation, clotting
cascade activation, cytokine release, nonspecific cellular inflammatory response, and
macrophage-mediated inflammation occurs.  The second phase is the proliferative phase.
This occurs during 3-42 days.  At this time, neovascularization, differentiation,
proliferation, and activation of cells and production of immature connective tissue matrix
is prevalent.  The maturation phase is the third phase.  This occurs after 28 days.  During
this time, remodeling of the immature bone matrix with coupled resorption and
deposition of bone is prevalent. Remodeling of bone in response to implant loading and
physiologic bone recession occurs.1
1.4 Bone/Implant Interface
The implant/bone interface has been evaluated for several years.  The direct bone
to implant interface between vital bone and screw-shaped titanium implants was proven
to achieve and maintain bone anchorage under loading.  This phenomenon is known as
4osseointegration.  This term is used to describe the “direct structural and functional
connection between ordered, living bone and the surface of a load carrying implant.”
Branemark and associates coined this term.  Branemark also demonstrated that titanium
could be predictably implanted and integrated into vital bone.6
1.5 Bone/Implant Wound Healing
The events of osseous wound healing parallel the healing of bone adjacent to
implants.  Implant substrate-osteoblast interactions may be characterized as specific,
protein-mediated, dynamic, signal-generating events.  Implant surface modification may
modulate this cell behavior.  After implantation, homeostasis, and clot formation,
fibrinolysis occurs with the formation of a loose connective tissue stroma that supports
angiogenesis.  The surface of the implants is conditioned with serum proteins, mineral
ions, sugars, lipids, as well as cytokines produced by immune cells.  The blood volume
around the implant will vary considerably as a function of the implant design and site.
The absence of relative paucity of serum proteins such as albumin indicates a selective
accumulation or deposition of molecules at the interface.  It has been stated that implant
surfaces provide anchorage for the fibrin clot to withstand detachment forces during cell
migration and thus maintains a pathway for the differentiating osteogenic cells to reach
the implant surface.7
1.6 Implant Surfaces
Implants must be made of a material that is compatible with bone.  Accepted
materials used in the fabrication of implants are classified into three groups: metals,
5ceramics, and polymers.  Each material can be further identified by its biocompatibility
as bioinert, biotolerant, and bioactive.  Bioinert materials allow close apposition on their
surface, leading to contact osteogenesis.  Materials considered bioinert include ceramics
such as aluminum oxide and zirconium oxide, and metals such as commercially pure
titanium and titanium alloys.  Biotolerant materials are not rejected when implanted in
tissue, but are surrounded by a fibrous layer to form a capsule.  Biotolerant metals and
polymers encompass gold, cobalt-chromium alloys, stainless steel, zirconium, niobium,
tantalum, polyethylene, polyamide, polymethylmethacrylate, and polytetrafluorethylene.
Bioactive materials allow for formation of new bone on their surface, exchanging ions to
create a chemical bond.  Polymers used a bioactive implant materials include
hydroxyapatite, tricalcium phosphates, tetracalcium phosphates, calcium phosphates,
fluorapatite, brushite, carbon: vitreous and pyrolytic, carbon-silicon and bioglass.
Bioactive and bioinert materials are osseoconductive, meaning they form a scaffold for
bone ingrowth.8
The implant-bone interface is a complex development. There are several factors
involved including materials, shape, topography, surface chemistry, mechanical loading,
surgical technique, patient bone quality, and quantity.  Creating topographic variations
from the mean surface plane of the implant can be achieved by additional methods such
as titanium plasma spraying, hydroxyapatite (HA) coating, coating with plasma,
magnetron sputter coating, calcium phosphate, and other attempts to coat an implant
surface with biological molecules.9
61.6.1. Methods and Modifications
Methods of implant surface modifications include abrasion through blasting with
titanium oxides or other soluble resorbable biomaterials, grits, or sand-blasting with
aluminous oxides, and blasting and acid-attacking or etching with a hydrogen sulfate or
hydrogen chloride material.9
Some surface treatments include anodizing, cold working (dimpling), sintering,
and bead compaction.  The surface energy, composition, topography, and roughness of an
implant are thought to affect bone formation and apposition.
Some important advantages have been linked to the differences in surface
roughness.  Implant surface modifications most frequently described in the literature may
be divided into: rough surfaces coated with a coating (ex.  Titanium plasma-sprayed of
hydroxyapatite coated implants).  Machine processed (ex.  Machined or polished)
titanium surfaces without a coating and rough surface implants without a coating (ex.
Sand-blasted or acid-etched).  These include increases surface area of the implant
adjacent to the bone.  There has been discussion of improved cell attachment to the
implant surfaces, increased bone present at the implant surface, and increased
biomechanical interaction of the implant with bone.10
After several studies, it has become known that rough-surfaced implants have
significantly higher success rates as compared to implants with turned surfaces.  The
surface roughness of titanium is one factor that helps in determining the balance between
bone formation and remodeling at the bone implant interface when compared to TPS and
7machine implants.  Bone-implant interface is positively correlated with increasing
roughness of the implant surface.10
1.6.2. Grit Blasting
Titanium oxides and aluminum oxides of various particle diameters are used to
abrade the surface of implants.  Grit blasting creates a surface of irregular pits and
depressions.  The particle size, time, pressure and distance create a range of desired
surface roughness.8  Blast polished titanium implants with 30 and 60 grit aluminum oxide
resulted in significantly more bone formation on the implant as well as a higher shear
strength at the implant-bone interface as compared to a polished titanium surface alone.8
The disadvantage to grit blasting is the potential for particles to remain embedded
on the implant surface disrupting osseointegration.11  Chemical exposure of a metallic
implant to acid etches may enhance osseointegration without adding particulate matter or
surface contaminants, eroding pits of specific dimension and shape.8  It has been
concluded that acid etched implants have a greater resistance to torque removal compared
to machined surface titanium.12  These results are interpreted as an increase in implant to
bone contact.
1.6.3. Porous Surfaces
Porous surfaces are differentiated from roughened surfaces by the lack of sharp or
jagged topography.  Pores are created by sintering spherical powders of metallic or
ceramic materials to the metallic core of an implant.  The pore size, shape, depth, and
volume are affected by the particle size, temperature, and pressure of the sintering
8process.13  Maximum bone ingrowth appears to occur at a pour depth of 150-300_m.14
The pore volume (porosity) directly affects the strength of the sintered coating to contact
metal.15
1.7 Hydroxyapatite
Hydroxyapatite (HA) is composed of calcium, phosphorous oxygen, and
hydrogen.  The chemical composition is as follows:
(Ca10(PO4)6(OH)2
The chemistry of HA lends itself to be similar to the mineral content of hard tissues such
as bone, teeth, and vertebrae.1  Significant efforts in multidisciplinary research have
sought to implicate the use of HA for numerous scientific applications such as separation
and purification of proteins, drug delivery systems, and bone implants.25, 26, 16  For each
application, the use of the calcium phosphate based material is optimized by specifying
its geometry, dimension, density, pore size, mechanical strength, purity, and chemical
phase.
HA was developed as coatings for dental and orthopedic implants to combine the
bioactive surface HA with the strength of titanium.8   The advantages of HA coatings lie
within its reported osseoconductive ability to improve the rate and strength of initial
implant integration.  Enhanced integration could result in earlier stability for prosthetic
loading.17
91.7.1. Commercial HA
Commercially available HA grain size is available from 45-160µm.18   However,
the large grain size of conventional HA also contributes to its physical weaknesses.
Smaller, denser HA feedstocks are the focus of commercial production bioceramics.  The
size dependent physical properties of materials reduced to the nanoscale can suddenly
show very different characteristics compared to what they exhibit on the macroscale,
enabling unique applications.19
The chemical compositions of HA coating can vary in percent composition of
crystalline HA, α or β-tricalcium phosphates, calcium oxides, calcium pyrophosphates,
and amorphous CaP.  HA coating crystallinity, phase composition, quantity and type
porosity all determine the reactive properties and subsequently the osseointegration
potential of the coating.  Surface reactions include following a cascade of events
including the dissolution of HA, precipitation of the apatite, ion exchange accompanied
by absorption and incorporation of biological molecules, cell attachment proliferation and
differentiation, and extracellular matrix formation and mineralization.20
1.7.2. Dissolution HA
The rate of dissolution is associated with the crystallinity of a prepared HA
coating.  The crystallinity of HA describes the percent of chemical composition in
crystalline from within any given HA coating.  The rate of dissolution is affected by the
ratio of crystalline HA to metastable compounds such as amorphous calcium, calcium
oxide, α or β-tricalcium phosphate, and tetra calcium phosphate within HA that either
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inherent or produced during the application of the coating to an implant substrate.  These
metastable constituents are more soluble than HA leading to an increase in dissolution.20
1.7.3. HA Coatings
Plasma-sprayed hydroxyapatite- coated implants are biocompatible and promote
early osseointegration by facilitating healing at the cellular level when compared to non-
coated titanium implants.  This promotion of early osseointegration has been attributed to
the increase in strength at the bone-implant surfaces.  However, problems with the
plasma-sprayed HA coatings have included variation in bond strength at the coating-
metal interface, non-uniformity in coating thickness between vendors, alteration in
structural and chemical properties, non-uniformity in coating density.9,20,21
One of the greatest concerns about the use of plasma-sprayed HA coated implants
is the general lack of long-term documentation on implant survival.  Over the years, vast
amounts of in vivo research has indicated biocompatibility with HA-coated implants and
a better performance when compared to non-coated titanium implants. As a result of
these problems, there is a controversy over whether or not HA coatings are beneficial to
implant success. However, these problems are not shortcomings inherent in the rationale
for HA coating, but rather in the plasma spray technology currently used for depositing
HA coatings on implant surfaces.22,23
1.7.4. Plasma Sprayed HA Preparation
Plasma spraying is the current commercial method for producing HA coatings in
implant surfaces.  A DC electric arc is struck between two electrodes and an ionized high
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temperature gas (up to 30,000°C) resulted as a stream of gases passing through the
electric arc.  The increase in gaseous temperature resulted in an expansion of the gas
causes the carrier gas stream to pass through the arc approximately the speed of sound.
The coating powder, suspended in the carrier gas stream is then fed into the plasma
flame.  The heat content of the plasma flame and thus the ability to increase the
temperature of a particle is strongly dependent on the type of gas used.  In addition, the
longer the particle remains in the plasma flame, the higher will be the plasma
temperature.  Ideally, only a thin outer layer of each powder particle gets into the molten
plastic state which undergoes some phase transitions.  This molten plastic state is critical
to ensure an adhesive and dense coating.  As a result, properties of the plasma sprayed
coatings is highly dependent on particle size, type of gas used, speed of the plasma, the
distance between the implants and plasma nozzle, and the cooling rate for the desired
structural and chemical properties.22
Apatite is known to be thermodynamically unstable during plasma spraying at
high temperatures.  When HA is plasma sprayed in air, calcium oxide is usually formed
and its concentration will affect the integrity of the plasma-sprayed HA coatings.  A poor
coating integrity is resulted from high concentration of calcium oxide reaction with
water.  In addition, an increase in calcium oxide can also be resulted from the presence of
a gas carrier resulted in a lower flame velocity and a more flame enthalpy as compared to
the use of nitrogen gas, thereby resulting in more melting and decomposition of HA
particles.  Plasma-sprayed HA coatings usually have a thickness of 50-100_m.  It is
desirable to have a plasma-sprayed coating that is completely dense and consists of pure
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HA.  As such, the Ca/P ration in the plasma-sprayed coating should be as similar to
natural HA.23
Aside from the weak coating-metal interface, vast amounts of investigations have
indicated that there are no accepted standards for producing HA coatings on implant
surfaces and that all HA coatings are not identical.  Variability in coating quality has
resulted in many conflicting animal and clinical observations.  Although plasma-sprayed
HA coatings on implant surfaces have been indicated to enhance implant stability, such
findings have not been universal.  Typical plasma-sprayed HA coatings have been
reported to consist primarily of partially dehydrated HA, with amorphous calcium
phosphate and other more soluble phases such as TCP produced during the high-
temperature deposition process.  Although plasma spraying has the ability to produce
coating crystallinity in the range of 30-70% the crystallinity for plasma-sprayed HA
coatings produced under normal deposition process are approximately 65%.  In addition,
the use of plasma spraying technology often results in coating properties that differs from
the starting HA powders.23,24
1.8 Tricalcium Phosphate Coatings
TCP is a scaffold which was approved by the FDA in the late 1900’s for use in
traumatic or surgical-created defects in the extremities, pelvis, and spine.  Small crystals
TCP (70-100nm) are formed into a 90% scaffold.  In the fully-interconnected
polyphorous structure, 75% of the pores range from 100-1000µm.  The remaining 24%
range from 1-100µm.  The macroporosity provides space in which bone in growth can
occur by osteoconduction.  The smaller pores may be less available for tissue ingrowth,
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but significantly enhance fluid flow and diffusion through the matrix, which may
improve the metabolic environment for cells within the matrix’s.  The microporosity also
provides a vehicle for promoting uptake of fluid and cells into the matrix capillary action
when the matrix is contacted with blood or marrow.  The porosity and the nanocrystalline
composition enhance dissolution and cell-mediated resorption after implantation and
during the bone remodeling.  Similar to interporous hydroxyapatite, the architecture of
the β-TCP scaffold resembles native trabecular bone.25
1.8.1. Tricalcium Phosphate Resorption
The resorption characteristics of TCP are consistent with data collected for this
material after in vivo implantation more than 25 years ago.  The resorption rate of
scaffold TCP is intended to match the course of natural bone healing after implantation.25
Pre-clinical evaluations have characterized the biologic performance of this
porous scaffold.  After implantation, the high porosity of the TCP allows rapid infiltration
by local cells and fluids.  In large metaphyseal defects of the canine humerus, quantitative
histomorphometric analysis showed the formation of bone through the porous scaffold in
conjunction with tricalcium resorption.  Significant bone formation was reported
throughout the implant as early as 3 weeks.  At 12, 24, and 52 weeks, the new bone in the
defect remodeled into a highly interconnected bone tissue indistinguishable from normal
adjacent bone. TCP resorption paralleled with bone in growth, with 76% resorbed at 6
weeks and 86% resorbed at 12 weeks.  At 52 weeks, less than 2% remained.25
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1.8.2. Adverse Effects and Indications
To date, no adverse events of failures have been observed.  However, no peer-
reviewed and published reports describing clinical efficacy are available.  The surface
area and porosity provided by TCP may make it an effective carrier for cells derived from
bone marrow and other sources.  Tricalcium phosphate maybe a useful carrier or delivery
system for some biologic and pharmaceutical agents, such as bone morphogenic proteins
and antibiotics.25
15
Chapter 2. Research Aims and Objectives
2.1 Specific Aims
• Determine the amount of cell attachment to the TCP-coated and HA-coated
surfaces in comparison to Ti (control).
• Determine the osteocalcin levels on the TCP-coated and HA-coated surfaces in
comparison to Ti (control).
• Determine the alkaline phosphatase specific activity on the TCP-coated and HA
coated surfaces in comparison to Ti (control).
2.2 Hypotheses
• TCP-coated titanium will cause an increase in cell attachment when compared to
HA-coated titanium and Ti (control).
• TCP-coated titanium will cause an increase in alkaline phosphatase activity when
compared to HA-coated titanium and Ti (control).
• TCP-coated titanium will cause an increase in osteocalcin production when
compared to HA-coated titanium and Ti (control).
2.3 Project Significance
 HA and TCP coatings were produced using a modified sol-gel process and spin-
coated on Ti surfaces. The chemical composition and crystallinity of the applied coating
was precisely controlled over a wide range of values, permitting optimization of the
coating for the promotion of osseointegration.  The coatings were deposited as thin films
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from 1-5µm thick using this innovative process, much thinner than coatings were applied
using plasma spraying technology and thus having a higher adhesive strength.  The sol-
gel coating process is not a line of sight process and thus allows a uniform coating to be
applied to roughened or beaded commercial dental implant surfaces.
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Chapter 3. Material and Methods
3.1 Titanium Substrates
Commercially pure grade 2 titanium (Ti) from Metal Samples, Munford, AL (14
mm diameter and 2 mm thick) were used in this study.  The Ti surfaces were wet ground
with 240, 400 and 600 grit silicon carbide paper.  Surface roughness measurement using
Surtornic 3 profilometer (Taylor-Hobson, UK) indicated a Ra value of 0.37 ± 0.01 µm.
After grinding, the Ti surfaces were degreased and cleaned by ultrasonically immersing
them in acetone and ethanol for 10 minutes each.  This was followed by deionized water
rinsing between applications of each solvent.  Following degreasing and cleaning, the Ti
surfaces were passivated by exposing the surfaces to a 40% volume nitric acid solution at
room temperature for 30 minutes (ASTM F86-76).  All surfaces were rinsed with
deionized water after passivation and air-dried. The non-coated Ti surfaces were then
used as controls or be subject to hydroxyapatite (HA) or tricalcium phosphate (TCP)
coatings.
3.2 Coatings
In this study, HA and TCP sol were used as coatings on Ti implant surfaces.  The
HA or TCP sol was prepared by reacting calcium nitrate tetrahydrate [Ca(NO3)2·4H2O]
(Aldrich) with the triethyl phosphite [(OC2H5)3P] (Fluka) in methyl alcohol using correct
amounts to obtain the stoichiometric Ca/P ratio.  This was followed by the addition of
0.03 mol of HCl and 0.1 mol of DCCA (Drying Control Chemical Additive). All work
was performed in argon atmosphere. The mixed solution was then aged at 80ºC for 12
18
hours. The aged solution was filtrated through a 0.2M syringe filter, and then be aged
again at 50ºC for 7 days.  After aging, HA or TCP coatings was then spin-coated on Ti
surfaces at 3500 rpm for 30 seconds.  The coated-Ti surfaces were immediately dried at
70ºC for 12 hours and then heat-treated at 650ºC for 3 hours.  All samples were
autoclaved prior to culture experiments.
3.3 Osteoblast Cell Culture
The osteoblast cell culture study was performed with the ATCC CRL 1486 human
embryonic palatal mesenchyme cell line (HEPM), a precursor of osteoblast cells.  The
cells were suspended in Dulbecco’s modified Eagle’s medium (DMEM) containing 10%
FBS, L-ascorbic acid, α-glycerophosphate, 2.5 x 10-9 M 1,25 (OH)2 vitamin D3 and a 1%
antibiotic/antimycotic mixture of penicillin, streptomycin and fungizone.  Experiments
were conducted in a 5% CO2 humidified incubator 37°C, and the medium was changed
twice a week.  Sterilized HA (controls), Ti (controls), and Tri-calcium phosphate coated
surfaces were placed at the bottom of a 24-well plate.  Samples were subsequently
assayed for cell attachment, proliferation activity, and alkaline phosphatase activity.
Human embryonic palatal mesenchyme cells were used for determining the total protein
production, alkaline phosphatase specific activity, and 1,25 (OH)2 vitamin D3 stimulated
osteocalcin production on different Ti surfaces.  Sterilized surfaces were placed at the
bottom of a well of 24-well plate.  One 100 ml of each osteoblast cell suspension was
seeded into each well.  Four replicates were conduced for each experimental point.  The
cultures were assayed at 0,4, 8, and 12 days.
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3.4 Cell Attachment
At 30, 60, 120, and 180 minutes after seeding, cells attached on each surface were
evaluated.  A 200 µl cell suspension (44,000 cells) were seeded on each surface.  At each
time point, triplicate samples from each group were assayed by removing the media and
washing the samples twice with PBS.  The total volume of PBS used for each was 200 µl.
The removed media and washed solution was saved and recorded as total volume.  The
number of unattached cells in the removed media and wash solution were subsequently
determined using Beckman Z2 Coulter Counter.  Cells attached on each surface were
measured by subtracting the unattached cell concentration from the initial cell
concentration seeded.  Mean attachment cell concentrations between the different
surfaces were statistically analyzed using the ANOVA, with the differences compared
using Tukey’s procedure.  The alpha level for data analysis was set at 0.05, and
differences was considered significant if p<0.05.
3.5 Alkaline Phosphatase Activity
Alkaline phosphatase (ALP) activity was quantified by rinsing (twice) the cells
with PBS, followed by exposing the cells to 0.2% Triton-X-100 solution in order to
permeabolize the cell membranes.  The cells were then subjected to three freeze/thaw
cycles, ultrasonically homogenizing the samples for 15 minutes, and centrifuging to
remove large cellular debris.  The resulting supernatant was assayed for the release of p-
nitrophenol from p-nitrophenylphosphate (pH = 10.2) and its specific activity calculated
50µl of p-mitrophenyl phosphate substrate was added. Followed by incubation in the dark
at room temperature for 1 hour.  After stopping the reaction using 50µl of 1 M NaOH,
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and the absorbance was read at 405nm using microplate readers.  ALP activity of cells
from each surface were then calculated from prepared standards (Sigma, St. Louis, MO).
Results were calculated as nmol p-nitrophenol per hour and normalized to DNA as
measured by PicoGreen assay kit (Molecular probes Eugene, OR).  Data was plotted as
the normalized ALP activity at 3, 6, 9, and 12 days.  Significant differences in protein
levels were statistically evaluated using ANOVA with Student Newman Kuels procedure
as the post hoc test for evaluation of significant differences at p<0.05.
Alkaline phosphatase specific activity was assayed as follows: a 50 µl aliquot of
the same cell lysate used for protein determination was added to 50µl of working
reagents in a 96 well culture plate and incubated at 37% C for 1 hr.  The working reagent
consists of 1.5 M 2-amino-2 methyl-propanol (Sigma), 20 mM p nitrophenol phosphate
(Sigma) and 1 mM magnesium chloride (1:1:1).  The reaction was  stopped using 100 µl
of 1 N sodium hydroxide and the absorbance read at 4-5nm using a microplate reader.
Alkaline phosphatase specific activity was calculated using the previously determined
protein values.  Significant differences in protein levels was statistically evaluated using
ANOVA with Student Newman0Kuels procedure as the post hoc test for evaluation of
significant differences at p<0.05.
3.6 Osteocalcin Assay
Osteocalcin production was assayed as follows:  At the experimental time point,
media was removed and replaced with media containing 2.5 x 10-9M 1,25 (OH)2 vitamin
D3.  After 24 hours, the media was replaced again with media containing the 1,25 (OH)2
vitamin D3.  After 48 hours, the media was collected and frozen at -20°C.  The samples
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were then lyophilized using the speed-vac (Savant).  The 1,25 (OH)2 vitamin D3
osteocalcin production was measured using commercially available rat osteocalcin
radioimmunoassay reagents (Biomedical Technologies, MA).  The samples (25µl) was
added to the 100µl osteocalcin antiserum.  They were covered tightly and incubated at
37°C for 2.5 hrs.  The samples were then be aspirated completely and washed 3times
with .3mL phosphate-saline was buffer.  Then 100µl Streptavidin-Horseradish Peroxidase
reagent was added to each well.  The wells were incubated at room temperature for 30
minutes.  One volume of TMB solution (peroxidase substrate) with one volume of
hydrogen peroxide solution (BT-468) was mixed and set aside.  The plates were washed
as before and 100µl of substrate mix was added to each well, incubated at room
temperature in the dark, for 15minutes.  100µl of stop solution was added and absorbance
was measured immediately at 450nm.  The radioactive count of the samples was
correlated to a standard known osteocalcin concentration curve and differences in 1,25
(OH)2 vitamin D3 stimulated osteocalcin production was statistically compared using the
ANOVA test, with the Student Newman-Kuels procedure as the post-hoc test for the
evaluation of significant differences at p<0.05.
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Chapter 4. Results
Initial osteoblast attachment study was performed on titanium (control, HA
coated, and TCP coated surfaces.  As shown in Figure 4.1 at 30 minutes, HA surfaces
exhibited the lowest amount of osteoblast attachment, whereas Ti surfaces exhibited
highest amount of osteoblast attachment and TCP coated had the second highest
attachment percentages.  While the amount of cell attachment levels rose exponentially,
by 180 minutes.
After evaluating cell attachment at different times, it was discovered that there is a
significant difference between the cell attachment percentages at 30 minutes.  During this
time, the significant difference is largest between HA and titanium (control) surfaces.
There is a larger amount of cell attachment to titanium at this time as opposed to HA
coated titanium.  There is also a significant difference between HA coated and TCP
coated titanium at this time.  There is more cell attachment to TCP coatings than HA
coated titanium surfaces.
At 60 minutes, there is a significant difference in cell attachment on the titanium
surfaces.  The difference in coatings is evident when comparing Ti (control) and HA
coated titanium.  There is a higher amount of cell attachment to Ti (control) than HA
coated titanium.
At 120 minutes, there is no significant difference between the control or the
coated surface titanium.  There is, however, a significant difference between the HA
coatings when compared to the TCP coated surfaces.  There is more cell attachment to
the TCP coatings than the HA coatings.  When comparing the HA and Ti (control), there
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Figure 4.1: Initial Cell Attachment Study on Hydroxyapatite and Tricalcium
Phosphate Surfaces over 180 Minutes.
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is a significant difference between the two.  There is more attachment on the Ti (control)
surface than the HA coated surface.  When comparing the Ti (control) and TCP coated
surfaces, there is a significant difference between the two.  There is more cell attachment
on the Ti (control) surface than the TCP coated surface.
At 180 minutes, there is a significant difference between the Ti (control), TCP
coated, and HA coated titanium.  When comparing the Ti (control) and HA coated
surface, there is a significant difference between the two.  There is a higher amount of
cell attachment on the Ti (control) surface than the HA coated surface.  When comparing
the Ti (control) and TCP coated surface, there is a significant difference between the two
groups.  There is a higher amount of cell attachment on the Ti (control) surface than the
TCP coated surface.
Early alkaline phosphatase production is evaluated in Figure 4.2.  On day 3, there
is a significant difference in ALP activity the Ti (control), HA coated, and TCP coated
surfaces.  When comparing HA and TCP coated surfaces, there is a significant difference
between both groups.  There is a larger amount of ALP production in HA coated surfaces
as opposed to TCP coated surfaces.  When comparing Ti (control) and HA coated
surfaces, there is a significant difference between the two groups.  There is larger amount
of ALP production in HA as opposed to Ti (control) surfaces.
On day 6, there is no significant difference between al three groups.  There is no
significant difference when the groups are compared to each in pairs (i.e. HA vs TCP,
HA vs Ti (control), etc).
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Figure 4.2: Alkaline Phosphatase Activity.
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On day 9, there is no significant difference between al three groups.  There is no
significant difference when the groups are compared to each in pairs (i.e. HA vs TCP.
HA vs Ti (control), etc).
On day 12, there is no significant difference between al three groups.  There is no
significant difference when the groups are compared to each in pairs (i.e. HA vs TCP.
HA vs Ti (control), etc).
Osteocalcin production on all three surfaces is evaluated in Figure 4.3.  On day 3,
there is no significant difference between all three groups when observing osteocalcin
levels.  There is no significant difference when the groups are compared to each in pairs
(i.e. HA vs TCP. HA vs Ti (control), etc).
On day 6, there is no significant difference between all three groups.  There is no
significant difference when the groups are compared to each in pairs (i.e. HA vs TCP.
HA vs Ti (control), etc).
On day 9, there is no significant difference between all three groups. There is a
significant difference between Ti (control) and TCP coated surfaces.  There is a larger
amount of osteocalcin production in Ti (control) when compared to TCP coated surfaces.
On day 12, there is no significant difference between all three groups.  There is no
significant difference when the groups are compared to each in pairs (i.e. HA vs TCP.
HA vs Ti (control), etc).
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Chapter 5. Discussion
After evaluating the HA, TCP, and Ti (Control) materials, it is evident that the
TCP coated titanium does not induce larger amounts of osteoblastic proteins production
in the early stages of osseointegration.  During the cell attachment study, it became
evident that during the first 20-40 minutes cell attachment percentages tend to be highest
in the titanium with no coating and lowest in HA coated surfaces.  As the minutes
progress, both test groups and the controls tend to have the same percentage of cell
attachment.
 The coatings and preparations on the titanium disks may play a role in the cell
attachment percentages.  Cell attachment of osteoblasts to titanium depends on the
surface roughness of the material. It has been proven that osteoblasts attach more readily
to roughed surfaces (sandblasted and sandblasted/acid-etched) compared to polished or
acid-etched surfaces alone.  Roughened surfaces alone can support cell attachment of
osteoblasts proving that the surface alone is capable of controlled cell attachment.28  In
this study, Titanium was wet ground and left without a coating as opposed to the HA and
TCP coated titanium.  The roughened surface of the uncoated titanium allows for the
earlier initial cell attachment.  As the minutes progress, HA and TCP increase in cell
attachment percentages, but they never equal to uncoated titanium attachment levels.
Osteoblasts are rich in alkaline phosphatase.  While the function of alkaline
phosphatase (ALP) is unknown, it has been suggested that is plays a major role in bone
mineralization of newly formed bone.  Measurements of total serum ALP is useful when
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the amount from bone is exceptionally high and concentrations from other sources are not
increased and are stable.29
ALP activity was measured and compared between HA, TCP , and uncoated
titanium controls.  When (ALP) levels were evaluated, at day 3 HA has the highest
amount of ALP activity.  By day 12, uncoated titanium has the highest level of (ALP)
levels.   The increase in the uncoated titanium may again be due to the roughed surface
and increase osteoblast attachment to this material.  At 12 days, ALP on β-TCP coatings
have increased. This may be attributed to the fact that in several other studies it has been
proven that there is minimal bone ingrowth on calcium phosphate treated material.  It has
been shown that at 2 weeks, the strength of fixation to this material begins to increase.30
This may explain why there is such an increase in ALP attachment in TCP as we get
closer to 2 weeks.
Osteocalcin activity is a key biomarker in osteoblast production.  Osteocalcin is
the major noncollagen protein of the bone matrix.  The function of osteocalcin is not
clear, but it is thought to serve as a site for hydroxyapatite crystal.  In the process of the
matrix synthesis, some osteocalcin is released and circulates in blood with a short half-
life determined mainly by renal clearance.  Although no intact osteocalcin is released
during bone resorption, fragments are released in vitro and also during resorption and
formation.29
During the osteocalcin study, at 3 days, TCP had the largest amount of
osteocalcin production.  By day 12, uncoated titanium has the highest amount of
osteocalcin production but all three materials have had a decrease in osteocalcin
production overall.  This may be due to the fact that more osteoclasts are beginning to
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form around day 12.  With this being the case, there has been a decrease in osteocalcin
formation.  Another factor may be attributed to the dissolution rates of TCP and HA.
Over time, there tends to be a continual increase in the calcium and inorganic
phosphorous in HA and TCP.  The additional increase of inorganic phosphorous has been
suggested to slow down osteoblast differentiation and mineralization.31
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Chapter 6. Conclusion
In summary, during early cell attachment, there is a higher amount of cell
attachment in Ti (control) surfaces as opposed to the other tested surfaces.  As the test
progressed, all surfaces showed an increase in cell attachment, but Ti (control) had the
highest amount of cell attachment.
When evaluating ALP production, at day 3, HA coated surfaces had the highest
amount of ALP production.  As days continued, there was no significant difference
between any of the tested groups.
When evaluating osteocalcin production, there was no significant increase in the
amount of production between any of the groups until day 9.  At day 9. Ti had a much
larger  increase in the amount of osteocalcin production than TCP.  At the end of the
study, there was no major difference between any of the groups.
It was thus concluded from this study that TCP coatings did not increase cell
attachment, alkaline phosphatase production, or osteocalicn production in early adjcaent
bone formation when evaluating osteoblast cells.
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Chapter 7. Future Studies
In the future, more studies should be conducted using uncoated titanium (control)
comparing it to HA and TCP.  Suggested modifications for future studies are as follows :
• TCP concentrations should be evaluated at different concentration levels.  While
the same mediating factors are evaluated, it may be discovered that higher levels
of TCP amount to higher levels of cell attachment, ALP production, and
osteocalcin production. .
• The time period of the experiments need to be extended.  The cell attachment
needs to be evaluated at periods longer than 180 minutes.  ALP may need to be
evaluated for 24 days.  Osteocalcin production needs to be evaluated for 24 days..
• Ti (control) surfaces need to be sand blasted and evaluated as opposed to wet
grinding the surfaces.
• More cell markers need to be evaluated.  Instead of looking at osteocalcin,
osteopontin production should be evaluated.
• Osteoclast cells need to be evaluated due to the fact that bone formation is also
dependent on bone resorption.
• All three of these surfaces should be evaluated in animal studies.
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